Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2012
05/31/2012WO2012036983A3 Removal of toxins from gastrointestinal fluids
05/31/2012WO2012003290A3 Dental composites comprising nanoparticles of amorphous calcium phosphate
05/31/2012US20120137379 Novel aav's and uses thereof
05/31/2012US20120136057 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis
05/31/2012US20120136052 Substituted acylanilides and methods of use thereof
05/31/2012US20120136043 Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field
05/31/2012US20120136034 Fatty acids as anti-inflammatory agents
05/31/2012US20120136026 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
05/31/2012US20120136019 (s)-n-methylnaltrexone
05/31/2012US20120136018 Quinolines
05/31/2012US20120136003 Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives
05/31/2012US20120136001 Substituted oxindole derivatives, medicaments containing the latter and use thereof
05/31/2012US20120136000 Tri-cyclic pyrazolopyridine kinase inhibitors
05/31/2012US20120135994 Inhibitors of human phosphatidylinositol 3-kinase delta
05/31/2012US20120135991 Orally rapidly disintegrating tablet that contains two or more types of particles
05/31/2012US20120135982 5HT2c RECEPTOR MODULATORS
05/31/2012US20120135978 6,7-unsaturated-7-carbamoyl substituted morphinan derivative
05/31/2012US20120135975 Substituted Esters as Cannabinoid-1 Receptor Modulators
05/31/2012US20120135971 Estrogen antagonists as treatments for sclerosing disorders
05/31/2012US20120135967 Lpa receptor agonists and antagonists and methods of use
05/31/2012US20120135959 Metalloprotein inhibitors containing nitrogen based ligands
05/31/2012US20120135958 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
05/31/2012US20120135932 Compositions And Methods For Treating Ischemia And Ischemia-Reperfusion Injury
05/31/2012US20120135916 Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
05/31/2012US20120135501 Recombinant poxvirus expressing homologous genes inserted
05/31/2012US20120135090 Solutions comprising polyethylene glycol and electrolytes
05/31/2012US20120135068 Liposome-encapsulated glutathione for oral administration
05/31/2012US20120135066 Regulators of the hedgehog pathway, compositions and uses related thereto
05/31/2012US20120135041 Immunosuppressor based on the blockage of tcr-nck interaction
05/31/2012US20120135036 Bacterial composition and its use
05/31/2012US20120135022 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3
05/31/2012US20120135011 Method for in vivo expansion of T regulatory cells
05/31/2012US20120135007 Anti-LPS Enriched Immunoglobulin Preparations For The Treatment And/Or Prophylaxis Of A Pathologic Disorder
05/31/2012US20120135005 ANTI-TNF-a ANTIBODIES AND THEIR USES
05/31/2012US20120134998 Secreted ap2 and methods of inhibiting same
05/31/2012US20120134997 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
05/31/2012US20120134966 Embryonic stem cell specific micrornas promote induced pluripotency
05/31/2012US20120134961 Interferon-alpha (IFN-alpha) Fused Protein Having IFN-alpha and Cytoplasmic Transduction Peptide (CTP)
05/31/2012US20120134958 Hydroxyethyl starch-containing polypeptide compositions
05/31/2012CA2856101A1 Immunomodulatory compositions
05/30/2012EP2458005A1 Fgf21 cis-element binding substance
05/30/2012EP2457561A1 Tablet having hollow structure
05/30/2012EP2456761A2 Potent small molecule inhibitors of autophagy and methods of use thereof
05/30/2012EP2456451A1 Inhibitor of inflammatory conditions
05/30/2012EP2456443A1 Treatment of liver disorders with pi3k inhibitors
05/30/2012EP2456432A1 Methods and compositions to reduce oxidative stress
05/30/2012EP2456428A1 Selective cb2 receptor agonists for use in the prevention or treatment of alcoholic liver disease
05/30/2012EP2456318A1 Crude caffeine complex, improved food products using the crude caffeine complex, and methods of use thereof
05/30/2012EP2231652B1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
05/30/2012EP2214673B1 Phenyl-substituted piperazino-dihydrothienopyrimidines
05/30/2012EP2123291B1 Use of Lactobacillus amylovorus for treating periodontal diseases by stimulating IgA production
05/30/2012EP1928551B1 Methods to reduce oxalate concentration by administration of oxalate oxidase crystals
05/30/2012EP1797858B1 Composition for oral cavity
05/30/2012CN202236455U Chinese medicinal powder for treating spleen channel tissue disease and package
05/30/2012CN202236454U Traditional Chinese medicine slurry capable of treating diseases in spleen channel tissue and package
05/30/2012CN202236453U Traditional Chinese medicine soup for treating gallbladder and liver tissue diseases and package thereof
05/30/2012CN202236452U Traditional Chinese medicine soup for treating gallbladder and heart tissue diseases and package thereof
05/30/2012CN202236451U Traditional Chinese medicine soup for treating diseases of tissues of common bile and spleen channel and packaging
05/30/2012CN202236450U Traditional Chinese medicine slurry and package combination for treating complications of tissues of small intestine and stomach channels
05/30/2012CN202236449U Traditional Chinese medicine soup for treating small intestine and stomach tissue diseases and package thereof
05/30/2012CN202236448U Chinese medicine powder for treating combined small intestine and lung tissue diseases and packages thereof
05/30/2012CN202236447U Traditional Chinese medicine slurry capable of curing tissue diseases of combination intestinum tenue and lung channel and package thereof
05/30/2012CN202236446U Traditional Chinese medicine decotion and package for treatment of associated small intestine and lung meridian diseases
05/30/2012CN202236445U Chinese medicine powder for treating liver tissue diseases and packages thereof
05/30/2012CN202236439U Traditional Chinese medicine soup for treating liver tissue diseases and package thereof
05/30/2012CN202236365U Heath capsule structure
05/30/2012CN202236345U Device for treating combined small intestine channel and lung channel tissue diseases by Chinese medicine
05/30/2012CN1919873B Fusion albumen containing HSP70 ATPase structure field and mammal p53 albumen and application thereof
05/30/2012CN1886506B Protein expressed in nk cell
05/30/2012CN1726048B Gastric acid secretion inhibiting composition
05/30/2012CN102482664A Marker for predicting therapeutic effect on hepatitis c, method for predicting therapeutic effect on hepatitis c, and prophylaxis or therapeutic agent for hepatitis c
05/30/2012CN102482662A 硫化氢生成酶抑制剂 Hydrogen sulfide generation inhibitors
05/30/2012CN102482316A 熊去氧胆酸-合成水滑石-丙烯酸树脂杂合体、包含该杂合体的药物组合物及其制备方法 UDCA - synthetic hydrotalcite - acrylic resin hybrid, the hybrid containing a pharmaceutical composition and a method for preparing
05/30/2012CN102482235A 苯并噁嗪酮化合物的结晶 Crystalline compounds benzoxazinone
05/30/2012CN102481362A 表皮生长因子受体(egfr)与蛋白酶活化受体2(par2)对肠道通透性的调节 Epidermal growth factor receptor (egfr) and protease-activated receptor 2 (par2) on the regulation of intestinal permeability
05/30/2012CN102481333A Immunity inducer
05/30/2012CN102481328A Extract Of Picrorhiza Kurroa Plants And A Process For Making The Same
05/30/2012CN102481322A Bacterial compositions for prophylaxis and treatment of degenerative disease
05/30/2012CN102481315A Antacid And Laxative Tablet
05/30/2012CN102481276A Chemosensory receptor ligand-based therapies
05/30/2012CN102481009A 包含外源性核苷酸的营养组合物 The nutritional composition comprises an exogenous nucleotide
05/30/2012CN102477453A 一种从黄杞叶中制备花旗松素单体的方法及用途 A leaf from the Engelhardtia prepared Taxifolin monomers and uses
05/30/2012CN102477386A 一种改善便秘保健酒 A method for improving constipation health wine
05/30/2012CN102477385A 一种益肝护肾保健酒 One kind of liver and kidney health wine
05/30/2012CN102477382A 一种男士保健酒 One kind of men's health wine
05/30/2012CN102477378A 一种壮阳保健酒 An aphrodisiac health wine
05/30/2012CN102477374A 一种开胃保健酒 One kind of appetizer health wine
05/30/2012CN102477371A 一种补血保健酒 One kind of blood health wine
05/30/2012CN102477370A 一种补肾保健酒 One kind of kidney health wine
05/30/2012CN102477078A 胸腺体液因子(THF)-γ2改构肽的制备及其药物组合物的用途 Preparation and use of pharmaceutical compositions thymic humoral factor (THF) -γ2 the altered peptide
05/30/2012CN102477065A 一种制备布地奈德的新16,17-缩酮中间体 A method of preparing a new 16,17 budesonide ketal intermediates
05/30/2012CN102477064A 一种制备环索奈德的新的16,17缩酮中间体 A ciclesonide new intermediates for the preparation of 16, 17-ketal
05/30/2012CN102477059A 一种高纯度牛磺熊去氧胆酸及其制备方法 A high-purity tauroursodeoxycholic acid and its preparation method
05/30/2012CN102477058A 一种制备布地奈德的新的16,17-二羟基中间体 A process for producing budesonide new 16,17-dihydroxy intermediate
05/30/2012CN102477012A 可抑制人2型11β-羟基类固醇脱氢酶活性的姜黄素类似物的制备及其应用 Inhibit human type 2 11β- hydroxysteroid dehydrogenase activity of preparation and application of curcumin analogues
05/30/2012CN102475883A 一种治疗癌症的药物 A treatment for cancer
05/30/2012CN102475881A 胃溃疡防治口服液 Oral Ulcer Prevention
05/30/2012CN102475879A 胃炎防治片 Gastritis prevention sheet
05/30/2012CN102475875A 一种外用中药制剂及其生产方法 A topical Chinese medicine and its production method
05/30/2012CN102475874A 疏肝益脾片 Liver and spleen slices
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 1258